{"createdAt":"8/2/2020, 2:23:09 PM","timestamp":1596392589471,"Company ID number":"510","DMX_ISSUER_NAME":"Hubei Biocause Pharmaceutical Co., Ltd","DMX_ISSUER_ID":"IID000000002169685","Country of Classification":"CHINA","name":"Hubei Biocause Pharmaceutical Co Ltd ","code":"000627","stock_exchange":"Shenzhen Stock Exchange","people":[{"id":"天茂实业集团股份有限公司_刘益谦","group":"board","name":"刘益谦","title":"董事长,董事","isMale":true,"age":"57","degree":"高中","salary":"0.00","stockAmount":"6.375亿","description":"刘益谦,男,中国国籍,无境外永久居留权,1963年11月生,中学学历。曾任安盛天平财产保险股份有限公司董事、中体产业集团股份有限公司董事,公司第四届董事会董事长。现任新理益集团有限公司执行董事、国华人寿保险股份有限公司董事长,天茂实业集团股份有限公司第七届董事会董事长。","lastUpdated":"2018-08-29"},{"id":"天茂实业集团股份有限公司_周文霞","group":"board","name":"周文霞","title":"副董事长,董事","isMale":false,"age":"48","degree":"硕士","salary":"--","stockAmount":"-","description":"周文霞女士,女,中国国籍,无境外永久居留权,1972年5月生,研究生学历。曾任湖北文化旅游投资集团副总经理、党委委员。现任国华人寿保险股份有限公司党委书记、国华保合健康养老产业发展有限公司董事长兼总经理。","lastUpdated":"2020-06-13"},{"id":"天茂实业集团股份有限公司_龙飞","group":"board","name":"龙飞","title":"董事","isMale":true,"age":"41","degree":"本科","salary":"14.24万","stockAmount":"-","description":"龙飞,男,中国国籍,无境外永久居留权,1979年5月生,本科学历。曾任天茂实业集团股份有限公司证券事务代表、董事会办公室主任、董事会秘书职务,于2005年4月通过深圳证券交易所董事会秘书资格考试。现任天茂实业集团股份有限公司第八届董事会董事会秘书。","lastUpdated":"2020-06-13"},{"id":"天茂实业集团股份有限公司_陈大力","group":"board","name":"陈大力","title":"董事","isMale":true,"age":"53","degree":"本科","salary":"1.000万","stockAmount":"-","description":"陈大力先生,男,中国国籍,无境外永久居留权,1967年7月出生,本科学历、高级会计师。曾任湖北中天集团公司财务总监、总会计师,天茂实业集团股份有限公司董事、财务总监、董事会秘书,北京匡时国际拍卖有限公司财务总监。现任上海坤茂置业有限公司董事长、国华人寿保险股份有限公司全资子公司武汉平华置业有限公司财务总监。","lastUpdated":"2020-06-13"},{"id":"天茂实业集团股份有限公司_田熠菲","group":"board","name":"田熠菲","title":"董事","isMale":true,"age":"38","degree":"硕士","salary":"1.500万","stockAmount":"-","description":"田熠菲,男,澳洲国籍,1982年2月生,悉尼大学媒体实践硕士。曾任洲际酒店集团大中华区高级营运经理;Camus集团大中华区品牌总监;光与盐集团创始人。2015年10月至今担任新理益集团有限公司董事长助理。","lastUpdated":"2018-08-29"},{"id":"天茂实业集团股份有限公司_石文清","group":"board","name":"石文清","title":"董事","isMale":true,"age":"53","degree":"本科","salary":"1.500万","stockAmount":"-","description":"石文清先生,男,中国国籍,无境外永久居留权,1967年8月出生,大学文化,中共党员。曾任荆门市统计局法制科负责人;荆门市后港镇人民政府副镇长;荆门市物资集团公司副总经理、总经理、党委书记;荆门市生态文化旅游开发集团有限公司党委副书记、总经理。现任天茂实业集团股份有限公司第六届董事会董事。","lastUpdated":"2018-08-29"},{"id":"天茂实业集团股份有限公司_毕建林","group":"board","name":"毕建林","title":"独立董事","isMale":true,"age":"64","degree":"硕士","salary":"12.00万","stockAmount":"-","description":"毕建林,男,高级政工师,研究生学历.1983年7月,北京大学毕业,获文学学士学位.1986年7月,中国政法大学研究生院毕业,获法学硕士学位.1986年8月-1993年7月,国务院法制局(现为国务院法制办公室)工作,任副处长.1993年7月-1998年12月,中国医药报社工作,任部主任.1999年1月至今,北京市众天中瑞律师事务所专职律师,主要从事企业改制、并购、重组以及证券等法律事务,已参与数家企业的改制、重组及公司发行股票和上市工作.","lastUpdated":"2018-08-29"},{"id":"天茂实业集团股份有限公司_徐翔","group":"board","name":"徐翔","title":"独立董事","isMale":true,"age":"50","degree":"大专","salary":"12.00万","stockAmount":"-","description":"徐翔先生,男,中国国籍,无境外永久居留权,1970年5月生,大专学历。曾任中国亚太贸易有限公司湖北分公司总经理,湖北新锐科技发展有限公司董事长、总经理,公司第三届、第四届董事会独立董事,罗牛山股份有限公司董事。现任天茂实业集团股份有限公司第八届董事会独立董事,嘉赐新能源投资股份有限公司董事长。","lastUpdated":"2018-08-29"},{"id":"天茂实业集团股份有限公司_刘万富","group":"board","name":"刘万富","title":"独立董事","isMale":true,"age":"56","degree":"硕士","salary":"12.00万","stockAmount":"-","description":"刘万富先生,男,中国国籍,无境外永久居留权,1964年11月生,研究生学历。曾任湖北瑞达信会计师事务有限公司主任会计师,大信会计师事务所有限公司总经理助理,上海龙凯会计师事务所有限公司主任会计师。现任天茂实业集团股份有限公司第八届董事会独立董事,宏祥新材料股份有限公司独立董事、瑞华会计师事务所(特殊普通合伙)合伙人。","lastUpdated":"2018-08-29"},{"id":"天茂实业集团股份有限公司_吴时炎","group":"supervisoryCommittee","name":"吴时炎","title":"监事会主席","isMale":true,"age":"57","degree":"本科","salary":"18.31万","stockAmount":"-","description":"吴时炎,男,1963年2月出生,大学文化。曾任荆门市化工厂厂办副主任、聚合车间党支部书记、党委副书记、副厂长及湖北中天集团公司总经理助理、工会主席等职务,现任天茂实业集团股份有限公司工会主席。公司第七届监事会监事会主席。","lastUpdated":"2018-08-29"},{"id":"天茂实业集团股份有限公司_沈坚强","group":"supervisoryCommittee","name":"沈坚强","title":"监事","isMale":true,"age":"48","degree":"大专","salary":"12.54万","stockAmount":"-","description":"沈坚强,男,1972年9月出生,大专学历,中国国籍,无永久境外居留权。1996年6月起进入公司财务部,天茂实业集团股份有限公司财务部经理助理、资金管理部副经理、经理等职务。现任天茂实业集团股份有限公司第八届监事会监事、财务部经理兼资金管理部经理。于2016年4月通过深圳证券交易所董事会秘书资格考试。","lastUpdated":"2018-08-29"},{"id":"天茂实业集团股份有限公司_卢俊","group":"supervisoryCommittee","name":"卢俊","title":"职工监事","isMale":false,"age":"48","degree":"硕士","salary":"--","stockAmount":"-","description":"卢俊女士,女,1972年6月出生,工商管理硕士研究生。曾任天茂实业集团股份有限公司总经理助理、国华人寿湖北分公司总经理助理、副总经理,现任国华人寿湖北分公司总经理。","lastUpdated":"2020-04-16"},{"id":"天茂实业集团股份有限公司_周文霞","group":"manager","name":"周文霞","title":"总经理","isMale":false,"age":"48","degree":"硕士","salary":"--","stockAmount":"-","description":"周文霞女士,女,中国国籍,无境外永久居留权,1972年5月生,研究生学历。曾任湖北文化旅游投资集团副总经理、党委委员。现任国华人寿保险股份有限公司党委书记、国华保合健康养老产业发展有限公司董事长兼总经理。","lastUpdated":"2020-06-13"},{"id":"天茂实业集团股份有限公司_龙飞","group":"manager","name":"龙飞","title":"董事会秘书","isMale":true,"age":"41","degree":"本科","salary":"14.24万","stockAmount":"-","description":"龙飞,男,中国国籍,无境外永久居留权,1979年5月生,本科学历。曾任天茂实业集团股份有限公司证券事务代表、董事会办公室主任、董事会秘书职务,于2005年4月通过深圳证券交易所董事会秘书资格考试。现任天茂实业集团股份有限公司第八届董事会董事会秘书。","lastUpdated":"2020-06-13"},{"id":"天茂实业集团股份有限公司_陈大力","group":"manager","name":"陈大力","title":"财务总监","isMale":true,"age":"53","degree":"本科","salary":"1.000万","stockAmount":"-","description":"陈大力先生,男,中国国籍,无境外永久居留权,1967年7月出生,本科学历、高级会计师。曾任湖北中天集团公司财务总监、总会计师,天茂实业集团股份有限公司董事、财务总监、董事会秘书,北京匡时国际拍卖有限公司财务总监。现任上海坤茂置业有限公司董事长、国华人寿保险股份有限公司全资子公司武汉平华置业有限公司财务总监。","lastUpdated":"2020-06-13"}],"companyName":"天茂实业集团股份有限公司","province":"湖北省","englishName":"Hubei Biocause Pharmaceutical Co.,Ltd","industry":"非银金融 — 保险","website":"www.tianmaogroup.net","mainBusiness":"从事化工和医药原料药的生产和销售","productsName":["保险","医药","化工"],"actualController":"刘益谦","actualControllerSharePercentage":"50.24%","registeredCapital":"49.41亿元","employeeAmount":"2314","phone":"86-0724-2223218","location":"湖北省荆门市东宝区杨湾路132号","chineseDescription":"天茂实业集团股份有限公司是一家横跨化工、医药两个产业，集新能源、合成树脂、原料药及中间体、医药制剂四个板块，100多个产品的公司，主要从事医药中间体、原料药以及各类医药制剂等产品的研究、开发和制造，二甲醚等新能源的制造等。公司的主要产品是二甲醚、布洛芬等。","foundedDate":"1993-11-18","goPublicDate":"1996-11-12","companyHistory":"","shareholders":[{"organizationId":"00011287","holderName":"新理益集团有限公司","totalShare":"20.82亿","sharePercentage":"42.13%"},{"organizationId":"","holderName":"刘益谦","totalShare":"6.38亿","sharePercentage":"12.90%"},{"organizationId":"","holderName":"王薇","totalShare":"5.56亿","sharePercentage":"11.25%"},{"organizationId":"","holderName":"民生加银基金-平安银行-民生加银鑫牛定向增发76号资产管理计划-民生中信建投南京5号定向资产管理计划","totalShare":"2.11亿","sharePercentage":"4.27%"},{"organizationId":"","holderName":"王扬超","totalShare":"7032.35万","sharePercentage":"1.42%"},{"organizationId":"","holderName":"渤海国际信托股份有限公司-渤海信托·恒利丰213号集合资金信托计划","totalShare":"6993.17万","sharePercentage":"1.42%"},{"organizationId":"T000125370","holderName":"香港中央结算有限公司","totalShare":"4967.53万","sharePercentage":"1.01%"},{"organizationId":"","holderName":"泰达宏利基金-平安银行-长安信托-长安信托·稳健增利1号集合资金信托计划","totalShare":"4501.78万","sharePercentage":"0.91%"},{"organizationId":"","holderName":"财通基金-浦发银行-粤财信托-粤财信托·弘盛1号单一资金信托计划","totalShare":"4177.22万","sharePercentage":"0.85%"},{"organizationId":"","holderName":"渤海国际信托股份有限公司-渤海信托·恒利丰210号集合资金信托计划","totalShare":"2079.70万","sharePercentage":"0.42%"}],"englishDescription":"Hubei Biocause Pharmaceutical Co.,Ltd. is a China-based company principally engaged in insurance business, such as life insurance, health insurance and casualty insurance. The Company is also involved in pharmaceutical business and chemical business. The Company鈥檚 products include polypropylene and Ibuprofen. The Company distributes its products in domestic market and to overseas markets, with Central China and South China as its main markets. ","englishIndustry":"Insurance (Life)","Price to earnings (ttm)":"15.49","Price to sales (ttm)":"0.63","Price to book (mrq)":"1.34","Price to cash flow (ttm)":"--","Total debt to equity (mrq)":"0.00","Lt debt to equity (mrq)":"0.00","Return on investment (ttm)":"--","Return on equity (ttm)":"1.50","Income statement":{"Total premiums earned":"39,643.21","Net investment income":"3,555.52","Realized & unrealized gains (losses)":"6,994.18","Other revenue, total":"(0.89)","Total revenue":"50,192.02","Losses, benefits, and adjustments, total":"37,088.11","Selling/general/admin. expenses, total":"5,655.87","Depreciation/amortization":"66.79","Unusual expense (income)":"666.72","Other operating expenses, total":"3,283.66","Total operating expense":"46,761.15","Operating income":"3,430.87","Other, net":"202.57","Net income before taxes":"3,633.44","Provision for income taxes":"714.89","Net income after taxes":"2,918.55","Minority interest":"(1,142.62)","Net income before extra. items":"1,775.94","Net income":"1,775.94","Income available to com excl extraord":"1,775.94","Income available to com incl extraord":"1,775.94","Diluted net income":"1,775.94","Diluted weighted average shares":"4,940.63","Diluted eps excluding extraord items":"0.36","Dps - common stock primary issue":"0.13","Diluted normalized eps":"0.47","Gain (loss) on sale of assets":"(0.10)","Interest exp.(inc.),net-operating, total":"30.58"},"Balance sheet":{"Cash":"0.07","Cash & equivalents":"15,891.36","Total receivables, net":"1,347.56","Total current assets":"17,238.99","Property/plant/equipment, total - gross":"635.71","Accumulated depreciation, total":"(50.53)","Property/plant/equipment, total - net":"585.19","Goodwill, net":"6,186.32","Intangibles, net":"109.42","Long term investments":"156,398.16","Insurance receivables":"322.21","Note receivable - long term":"24,433.66","Total assets":"205,273.95","Accounts payable":"1,016.73","Payable/accrued":"461.84","Policy liabilities":"168,392.49","Notes payable/short term debt":"0.00","Total current liabilities":"1,478.57","Long term debt":"0.00","Total long term debt":"0.00","Total debt":"0.00","Deferred income tax":"1,049.41","Minority interest":"13,130.42","Total liabilities":"184,050.89","Common stock, total":"4,940.63","Additional paid-in capital":"11,095.30","Retained earnings (accumulated deficit)":"6,025.91","Other equity, total":"(838.78)","Total equity":"21,223.05","Total liabilities & shareholders' equity":"205,273.95","Total common shares outstanding":"4,940.63","Tangible book value per share, common eq":"3.02","Current port. of  lt debt/capital leases":"6.50"},"Cash flow":{"Cash receipts":"38,011.62","Cash payments":"(1,734.84)","Cash taxes paid":"(1,029.46)","Changes in working capital":"(6,647.77)","Cash from operating activities":"28,599.56","Capital expenditures":"(717.10)","Other investing cash flow items, total":"(34,327.22)","Cash from investing activities":"(35,044.32)","Financing cash flow items":"(98.60)","Total cash dividends paid":"(242.12)","Issuance (retirement) of debt, net":"1,466.01","Cash from financing activities":"1,125.29","Foreign exchange effects":"(1.36)","Net change in cash":"(5,320.84)"},"keyMetrics":{"Price and Volume":{"Price closing or last bid":"5.74","52 Week High":"7.95","52 Week Low":"4.77","Pricing date":"","10 Day Average Trading Volume":"38.66","Market Capitalization":"28,359.21","52 Week High Date":"","52 Week Low Date":"","3 Month Average Trading Volume":"658.93","Beta":"0.79","1 Day Price Change":"-0.17","13 Week Price Return (Daily)":"4.17","26 Week Price Return (Daily)":"-11.42","5 Day Price Return (Daily)":"2.14","52 Week Price Return (Daily)":"-19.50","Year To Date Price Return (Daily)":"-18.47","Month to Date Price Return (Daily)":"10.17","Price Relative to S&P500 (4 Week)":"-9.62","Price Relative to S&P500 (13 Week)":"-18.10","Price Relative to S&P500 (26 Week)":"-30.62","Price Relative to S&P500 (52 Week)":"-45.29","Price Relative to S&P500 (YTD)":"-37.64"},"Per Share Data":{"EPS excl. Extra Items (Annual)":"0.36","EPS excl. Extra Items (TTM)":"0.37","EPS Normalized (Annual)":"0.47","Revenue per Share (Annual)":"10.16","Revenue per Share (TTM)":"9.13","Book Value (Per Share Annual)":"4.30","Book Value (Per Share Quarterly)":"4.29","Tangible Book Value (Per Share Annual)":"3.02","Tangible Book Value (Per Share Quarterly)":"3.01","Cash Per Share (Per Share Annual)":"3.22","Cash Per Share (Per Share Quarterly)":"5.62","Cash Flow (Per Share Annual)":"0.61","Cash Flow (Per Share TTM)":"--","Dividend (Per Share Annual)":"0.13","Dividends (Per Share TTM)":"0.13","EBITD (Per Share TTM)":"0.60","EPS Basic excl. Extra Items (Annual)":"0.36","EPS Basic excl. Extra Items (TTM)":"0.37","EPS incl. Extra Items (Annual)":"0.36","EPS incl. Extra Items (TTM)":"0.37","Free Cash Flow (Per Share TTM)":"3.29","Dividend (Per Share 5Y)":"0.04"},"Valuation":{"P/E excl. Extra Items (Annual)":"15.97","P/E excl. Extra Items (TTM)":"15.49","P/E Normalized (Annual)":"12.27","Price to sales (Annual)":"0.57","Price to sales (TTM)":"0.63","Price to Tangible Book (Annual)":"1.90","Price to Tangible Book (Quarterly)":"1.90","Price to Free Cash Flow (Per Share Annual)":"1.03","Price to Cash Flow (Per Share TTM)":"--","Price to Free Cash Flow (Per Share TTM)":"1.74","Price to Book (Annual)":"1.34","Price to Book (Quarterly)":"1.34","P/E Basic excl. Extra Items (TTM)":"15.97","P/E excl. Extra Items High (TTM)":"58.90","P/E excl. Extra Items Low (TTM)":"15.97","P/E incl. Extra Items (TTM)":"15.49","Net Debt (Interim)":"-27,758.95","Net Debt (Annual)":"-15,891.43","Dividend Yield (5Y)":"0.52","Dividend Yield":"2.26","Current Dividend Yield (TTM)":"2.26"},"Financial Strength":{"Free Cash Flow (Annual)":"27,640.34","Current Ratio (Annual)":"--","Net Interest coverage (Annual)":"--","Long Term Debt/Equity (Annual)":"0.00","Payout Ratio (Annual)":"36.17","Quick Ratio (Annual)":"--","Total Debt/Total Equity (Annual)":"0.00","Current EV/Free Cash Flow (Annual)":"--","Current EV/Free Cash Flow (TTM)":"--","Current Ratio (Quarterly)":"--","Long Term Debt/Equity (Quarterly)":"0.00","Quick Ratio (Quarterly)":"--","Total Debt/Total Equity (Quarterly)":"0.00","Free Cash Flow (TTM)":"16,273.09","Net Interest Coverage (TTM)":"--","Payout Ratio (TTM)":"35.08"},"Margins":{"Gross Margin (Annual)":"--","Gross Margin (TTM)":"--","Net Profit Margin % (Annual)":"5.81","Net Profit Margin (TTM)":"6.67","Operating Margin (Annual)":"6.84","Operating Margin (TTM)":"6.53","Pretax Margin (TTM)":"7.97","Pretax Margin (Annual)":"7.24","Operating Margin (5Y)":"8.23","Pretax Margin (5Y)":"8.36","Free Operating Cash Flow/Revenue (5Y)":"23.12","Free Operating Cash Flow/Revenue (TTM)":"36.07","Gross Margin (5Y)":"--","Net Profit Margin (5Y)":"7.43"},"Management Effectiveness":{"Return on Assets (Annual)":"1.52","Return on Equity (TTM)":"1.50","Return on Average Equity (Annual)":"8.83","Return on Average equity (TTM)":"8.83","Return on Investment (Annual)":"--","Return on Investment (TTM)":"--","Return on Average Assets (5Y)":"2.09","Return on Average Equity (5Y)":"9.90","Return on Investment (5Y)":"--","Asset Turnover (Annual)":"0.26","Asset Turnover (TTM)":"0.22","Inventory Turnover (Annual)":"--","Inventory Turnover (TTM)":"--","Net Income/Employee (Annual)":"1,001,391.00","Net Income/Employee (TTM)":"1,300,620.00","Receivables Turnover (Annual)":"--","Receivables Turnover (TTM)":"--","Revenue/Employee (Annual)":"17,221,480.00","Revenue/Employee (TTM)":"19,494,320.00"},"Growth":{"Revenue Growth (Quarterly YoY)":"-22.41","Revenue Growth Rate (5Y)":"128.46","EPS Growth (Quarterly YoY)":"16.70","EPS Growth (TTM YoY)":"38.97","EPS Growth Rate (5Y)":"42.15","Dividend Growth Rate (3Y)":"73.25","Revenue Growth (TTM YoY)":"19.23","Revenue Growth (Per Share 5Y)":"76.34","Revenue Growth Rate (3Y)":"43.48","EPS Growth Rate (3Y)":"-4.88","Book Value Growth Rate (Per Share 5Y)":"32.03","Tangible Book Value Total Equity CAGR (5Y)":"73.66","Capital Spending growth rate 5 year":"31.05","EBITDA CAGR (5Y)":"--","EBITDA Interim CAGR (5Y)":"--","Free Operating Cash Flow CAGR (5Y)":"--","Total Debt CAGR (5Y)":"--","Net Profit Margin Growth Rate (5Y)":"-11.03"},"Income Statement":{"Revenue (Annual)":"50,192.02","Revenue (TTM)":"45,109.86","EBITD (Annual)":"4,176.76","EBITD (TTM)":"2,942.95","Earnings Before Taxes (Annual)":"3,633.44","Earnings Before Taxes (TTM)":"3,593.12","Net Income to Common (Annual)":"1,775.94","Net Income to Common (TTM)":"1,830.94","Earnings Before Taxes Normalized (Annual)":"4,300.17","Net Income Available to Common Normalized (Annual)":"2,311.48","Diluted Normalized EPS excl. Extra Items (TTM)":"0.37"}}}